Home › Calculator › XTNT Dividend Calculator 2026
XTNT Dividend DRIP Calculator 2026
469.98% YieldHealthcareXtant Medical Holdings, Inc. · AMEX
Price: $0.43 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When XTNT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your XTNT snowball 📈
$10,000 in XTNT → $723471236525042688.00M in 10 years · $60,273,080,799,219,770,000,000.00/month
About Xtant Medical Holdings, Inc. (XTNT) — Dividend Analysis 2026
Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.
Compare XTNT with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full XTNT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open XTNT position with:
🌍 XTNT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold XTNT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 469.98% | 467.18% | $46,998 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 399.48% | 396.68% | $39,948 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 375.98% | 373.18% | $37,598 / yr |
| 🇬🇧 UK ISA | 0% | 469.98% | 467.18% | $46,998 / yr |
| 🇬🇧 UK Taxable | 8.75% | 428.86% | 426.06% | $42,886 / yr |
| 🇨🇦 TFSA | 0% | 469.98% | 467.18% | $46,998 / yr |
| 🇨🇦 CA Taxable | 25% | 352.49% | 349.69% | $35,249 / yr |
| 🇦🇺 Super (pension) | 15% | 399.48% | 396.68% | $39,948 / yr |
| 🇦🇺 AU Taxable | 30% | 328.99% | 326.19% | $32,899 / yr |
| 🇩🇪 DE Taxable | 26.375% | 346.02% | 343.22% | $34,602 / yr |
| 🇫🇷 FR Taxable | 30% | 328.99% | 326.19% | $32,899 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 XTNT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 XTNT Dividend Payment Schedule
XTNT pays quarterly — 4 times per year. Next ex-div: TBD.
📊 XTNT vs Healthcare Benchmarks
How XTNT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for XTNT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ XTNT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-02-15 | 7,709 | $0.58 | $4.5K | ||
| F-InKind | 2026-01-15 | 8,084 | $0.65 | $5.3K | ||
| A-Award | 2025-11-15 | 158,228 | — | — | ||
| A-Award | 2025-11-15 | 553,797 | — | — | ||
| A-Award | 2025-11-15 | 158,228 | — | — | ||
| A-Award | 2025-11-15 | 158,228 | — | — | ||
| A-Award | 2025-11-15 | 158,228 | — | — | ||
| A-Award | 2025-11-15 | 158,228 | — | — | ||
| A-Award | 2025-11-15 | 394,937 | — | — | ||
| A-Award | 2025-11-15 | 789,874 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where XTNT earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the XTNT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Xtant Medical Holdings, Inc. (XTNT) is currently trading at $0.43, 90% below its 52-week high. The current dividend yield is 469.98% based on an annual payout of $2.00 per share.
XTNT (Xtant Medical Holdings, Inc.) — 469.98% Dividend Yield Analysis
Xtant Medical Holdings, Inc. (XTNT) is a healthcare stock currently trading at $0.43 with a dividend yield of 469.98%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (469.98%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.